Td Asset Management Inc Royalty Pharma PLC Transaction History

Td Asset Management Inc

  • $102 Billion
  • Q1 2025

A detailed history of Td Asset Management Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Td Asset Management Inc holds 83,211 shares of RPRX stock, worth $2.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
83,211
Previous 55,493 49.95%
Holding current value
$2.73 Million
Previous $1.42 Million 83.04%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 07, 2025
BUY
$25.75 - $33.86 $713,738 - $938,531
27,718 Added 49.95%
83,211 $2.59 Million
Q4 2024

Feb 11, 2025
BUY
$24.28 - $28.39 $254,915 - $298,066
10,499 Added 23.33%
55,493 $1.42 Million
Q3 2024

Nov 01, 2024
BUY
$25.63 - $29.27 $21,067 - $24,059
822 Added 1.86%
44,994 $1.27 Million
Q2 2024

Aug 02, 2024
SELL
$26.26 - $29.9 $653,348 - $743,912
-24,880 Reduced 36.03%
44,172 $1.16 Million
Q1 2024

May 08, 2024
SELL
$27.46 - $31.33 $4.15 Million - $4.73 Million
-151,131 Reduced 68.64%
69,052 $2.1 Million
Q4 2023

Feb 12, 2024
SELL
$26.21 - $29.22 $1.84 Million - $2.05 Million
-70,300 Reduced 24.2%
220,183 $6.18 Million
Q3 2023

Oct 27, 2023
BUY
$26.26 - $31.38 $2.52 Million - $3.01 Million
96,026 Added 49.38%
290,483 $7.88 Million
Q2 2023

Aug 09, 2023
SELL
$29.6 - $36.56 $232,537 - $287,215
-7,856 Reduced 3.88%
194,457 $5.98 Million
Q1 2023

May 10, 2023
BUY
$32.77 - $39.4 $32,638 - $39,242
996 Added 0.49%
202,313 $7.29 Million
Q4 2022

Feb 06, 2023
BUY
$39.17 - $44.04 $387,312 - $435,467
9,888 Added 5.17%
201,317 $7.96 Million
Q3 2022

Nov 07, 2022
SELL
$39.88 - $44.65 $572,198 - $640,638
-14,348 Reduced 6.97%
191,429 $7.72 Million
Q2 2022

Aug 04, 2022
BUY
$37.53 - $44.22 $1.42 Million - $1.67 Million
37,742 Added 22.46%
205,777 $8.65 Million
Q1 2022

May 10, 2022
BUY
$37.46 - $42.44 $23,524 - $26,652
628 Added 0.38%
168,035 $6.55 Million
Q4 2021

Feb 10, 2022
BUY
$35.17 - $42.48 $454,220 - $548,629
12,915 Added 8.36%
167,407 $6.67 Million
Q3 2021

Nov 09, 2021
SELL
$36.14 - $42.24 $36,140 - $42,240
-1,000 Reduced 0.64%
154,492 $5.58 Million
Q2 2021

Aug 11, 2021
BUY
$39.85 - $46.63 $99,625 - $116,575
2,500 Added 1.63%
155,492 $5.94 Million
Q1 2021

May 14, 2021
BUY
$42.34 - $52.82 $245,572 - $306,356
5,800 Added 3.94%
152,992 $6.67 Million
Q4 2020

Feb 16, 2021
SELL
$36.12 - $50.05 $4.03 Million - $5.59 Million
-111,699 Reduced 43.15%
147,192 $7.37 Million
Q3 2020

Nov 10, 2020
BUY
$38.56 - $48.36 $2.7 Million - $3.39 Million
70,000 Added 37.06%
258,891 $10.9 Million
Q2 2020

Aug 13, 2020
BUY
$44.5 - $52.11 $8.41 Million - $9.84 Million
188,891 New
188,891 $9.17 Million

Others Institutions Holding RPRX

# of Institutions
483
Shares Held
283M
Call Options Held
2.51M
Put Options Held
941K
View Full List

About Royalty Pharma plc

RPRX Quotes by TradingView
  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $14.4B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email